Clinical Trial Update: A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Levodopa-Carbidopa intestinal gel to optimized medical treatment for non-motor symptoms in advanced Parkinson's disease; completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-motor Symptoms of Parkinson Disease
• Parkinson Disease

Drugs mentioned

• Levodopa-carbidopa intestinal gel (levodopa-carbidopa intestinal gel)
• Optimized medical treatment

Snippet

Sponsor: AbbVie | Conditions: Advanced Parkinson's Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-06-03